Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Healthcare Trust of America, Inc is a reit-healthcare facilities business based in the US. Healthcare Trust of America shares (HTA) are listed on the NYSE and all prices are listed in US Dollars. Healthcare Trust of America employs 303 staff and has a trailing 12-month revenue of around USD$729.9 million.
|Latest market close||USD$27.54|
|52-week range||USD$19.8536 - USD$32.9642|
|50-day moving average||USD$26.8306|
|200-day moving average||USD$26.3743|
|Wall St. target price||USD$29.62|
|Dividend yield||USD$1.28 (4.66%)|
|Earnings per share (TTM)||USD$0.15|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-12)||3.30%|
|1 month (2020-12-22)||-0.58%|
|3 months (2020-10-20)||9.46%|
|6 months (2020-07-20)||6.21%|
|1 year (2020-01-18)||N/A|
|2 years (2019-01-18)||2.49%|
|3 years (2018-01-19)||0.36%|
|5 years (2016-01-20)||2.84%|
Valuing Healthcare Trust of America stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Healthcare Trust of America's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Healthcare Trust of America's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 183x. In other words, Healthcare Trust of America shares trade at around 183x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Healthcare Trust of America's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$436.2 million.
The EBITDA is a measure of a Healthcare Trust of America's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$729.9 million|
|Operating margin TTM||21.27%|
|Gross profit TTM||USD$480.1 million|
|Return on assets TTM||1.48%|
|Return on equity TTM||1.05%|
|Market capitalisation||USD$6 billion|
TTM: trailing 12 months
There are currently 10.9 million Healthcare Trust of America shares held short by investors – that's known as Healthcare Trust of America's "short interest". This figure is 3.5% up from 10.6 million last month.
There are a few different ways that this level of interest in shorting Healthcare Trust of America shares can be evaluated.
Healthcare Trust of America's "short interest ratio" (SIR) is the quantity of Healthcare Trust of America shares currently shorted divided by the average quantity of Healthcare Trust of America shares traded daily (recently around 1.9 million). Healthcare Trust of America's SIR currently stands at 5.65. In other words for every 100,000 Healthcare Trust of America shares traded daily on the market, roughly 5650 shares are currently held short.
However Healthcare Trust of America's short interest can also be evaluated against the total number of Healthcare Trust of America shares, or, against the total number of tradable Healthcare Trust of America shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Healthcare Trust of America's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Healthcare Trust of America shares in existence, roughly 50 shares are currently held short) or 0.0659% of the tradable shares (for every 100,000 tradable Healthcare Trust of America shares, roughly 66 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Healthcare Trust of America.
Find out more about how you can short Healthcare Trust of America stock.
Dividend payout ratio: 75.15% of net profits
Recently Healthcare Trust of America has paid out, on average, around 75.15% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 4.66% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Healthcare Trust of America shareholders could enjoy a 4.66% return on their shares, in the form of dividend payments. In Healthcare Trust of America's case, that would currently equate to about $1.28 per share.
Healthcare Trust of America's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Healthcare Trust of America's most recent dividend payout was on 12 January 2021. The latest dividend was paid out to all shareholders who bought their shares by 4 January 2021 (the "ex-dividend date").
Healthcare Trust of America's shares were split on a 1:2 basis on 16 December 2014. So if you had owned 2 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Healthcare Trust of America shares – just the quantity. However, indirectly, the new 100% higher share price could have impacted the market appetite for Healthcare Trust of America shares which in turn could have impacted Healthcare Trust of America's share price.
Over the last 12 months, Healthcare Trust of America's shares have ranged in value from as little as $19.8536 up to $32.9642. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Healthcare Trust of America's is 0.5496. This would suggest that Healthcare Trust of America's shares are less volatile than average (for this exchange).
Healthcare Trust of America, Inc. (NYSE: HTA) is the largest dedicated owner and operator of MOBs in the United States, comprising approximately 25.1 million square feet of GLA, with $7.4 billion invested primarily in MOBs. HTA provides real estate infrastructure for the integrated delivery of healthcare services in highly-desirable locations. Investments are targeted to build critical mass in 20 to 25 leading gateway markets that generally have leading university and medical institutions, which translates to superior demographics, high-quality graduates, intellectual talent and job growth. The strategic markets HTA invests in support a strong, long-term demand for quality medical office space. HTA utilizes an integrated asset management platform consisting of on-site leasing, property management, engineering and building services, and development capabilities to create complete, state of the art facilities in each market. This drives efficiencies, strong tenant and health system relationships, and strategic partnerships that result in high levels of tenant retention, rental growth and long-term value creation. Headquartered in Scottsdale, Arizona, HTA has developed a national brand with dedicated relationships at the local level. Founded in 2006 and listed on the New York Stock Exchange in 2012, HTA has produced attractive returns for its stockholders that have outperformed the US REIT index.
Everything we know about the Cloopen Group Holding Limited IPO, plus information on how to buy in.
Everything we know about the Decipher Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Proterra IPO, plus information on how to buy in.
Everything we know about the Grab IPO, plus information on how to buy in.
Everything we know about the Deliveroo IPO, plus information on how to buy in.
Everything we know about the Terns Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Angion Biomedica Corp IPO, plus information on how to buy in.
Everything we know about the PurposeBuilt Brands Inc IPO, plus information on how to buy in.
Everything we know about the LumiraDx Limited IPO, plus information on how to buy in.
Everything we know about the Vor Biopharma Inc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.